ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A candidate prognostic biomarker: TFEB inhibits tumor progression via elevating CDKN1A in bladder cancer

Yue, Minghao; Yang, Zhe; Sun, Jiabin; Liu, Zan*哈尔滨医科大学; 1
International Immunopharmacology2023-12DOI: 10.1016/j.intimp.2023.111016
5阅读
引用收藏
分享

摘要

Bladder cancer(BC) is among the most prevalent malignancies in the world, with 549,393 new cases documented in 2018, and most BC patients have a poor prognosis. Transcription factor EB (TFEB) is considered a crucial controller of lysosomal-associated diseases, but a growing number of research in recent years have reported that TFEB plays other functions in tumors independent of lysosomal autophagy. In this study, we aimed to assess whether TFEB is a biomarker for BC and a molecular target for BC therapy. TFEB was lowly expressed in BC tissues relative to paracancerous tissues, and its elevated expression was strongly associated to a better prognosis for BC patients. TFEB overexpression markedly suppressed cell proliferation, limited cell migration, and accelerated apoptosis. Tumor growth in vivo was also suppressed. Mechanistically, we found that TFEB promoted CDKN1A expression by binding to the upstream progenitor of the CDKN1A promoter, which was also dependent on p53. Finally, Immune cell infiltration in BC tissues, PDL-1 expression, and Single-cell RNA sequencing data revealed immunotherapy may have a positive correlation with TFEB expression. Our study identifies that TFEB regulates CDKN1A in BC and has a positive prognostic value, while its expression is also positively correlated with immune cell infiltration. Therefore, TFEB may represent a recent therapeutic target for BC.

学科与关键词

关键词
TFEBBladder cancerCDKN1AP53Single-cell
相关
加载中…
  • TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
    Zhu, Xuejin; Zhuo, Yangjia; Wu, Shulin; Chen, Yanfei; Ye, Jianheng; Deng, Yulin; Feng, Yuanfa; Liu, Ren; Cai, Shanghua; Zou, Zhihao; Wang, Bin; Wu, Chin-Lee; Zeng, Guohua*; Zhong, Weide*Frontiers in Oncology, 2021, 11: 632524.被引 12
  • TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis (vol 11,32524, 2021)
    Zhu, Xuejin; Zhuo, Yangjia; Wu, Shulin; Chen, Yanfei; Ye, Jianheng; Deng, Yulin; Feng, Yuanfa; Liu, Ren; Cai, Shanghua; Zou, Zhihao; Wang, Bin; Wu, Chin-Lee; Zeng, Guohua*; Zhong, Weide*Frontiers in Oncology, 2021, 11: 750277.被引 2
  • FGFBP1 as a potential biomarker predicting bacillus Calmette-Guerin response in bladder cancer
    Li, Fei; Zhang, Henghui; Wang, Yu; Yao, Zhihao; Xie, Kunfeng; Mo, Qixin; Fan, Qin; Hou, Lina*; Deng, Fan*; Tan, Wanlong*Frontiers in Immunology, 2022, 13: 954836.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2023-12
卷期
第 125 卷
页码
111016
DOI
10.1016/j.intimp.2023.111016
语言
ENGLISH
成果收录
SCIE
资助标注
Postdoctoral Scientific Research Developmental Fund of Hei-longjiang Provence [LBH-Q19036]

作者

  • Y

    Yue, Minghao (第一作者)

    tianjin first cent hosp

  • Y

    Yang, Zhe

    1 · harbin med univ

查看全部 4 位作者收起作者
  • S

    Sun, Jiabin

    1 · jiamusi univ

  • L

    Liu, Zan (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417